A detailed history of Israel Englander (Millennium Management LLC) transactions in Grifols Sa stock. As of the latest transaction made, Millennium Management LLC holds 200,000 shares of GRFS stock, worth $1.81 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200,000
Previous 128,000 56.25%
Holding current value
$1.81 Million
Previous $855,000 47.37%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$6.27 - $7.7 $2.69 Million - $3.3 Million
-428,764 Reduced 2.99%
13,924,646 $87.7 Million
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $7.58 Million - $15.8 Million
-1,385,753 Reduced 8.8%
14,353,410 $95.9 Million
Q4 2023

Feb 14, 2024

BUY
$7.71 - $11.56 $11.9 Million - $17.9 Million
1,545,434 Added 10.89%
15,739,163 $182 Million
Q2 2023

Aug 14, 2023

BUY
$7.14 - $9.29 $6.24 Million - $8.12 Million
873,974 Added 6.56%
14,193,729 $130 Million
Q1 2023

May 15, 2023

BUY
$6.65 - $10.69 $25.3 Million - $40.7 Million
3,808,720 Added 40.05%
13,319,755 $98.2 Million
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $18.8 Million - $26.8 Million
3,146,341 Added 49.43%
9,511,035 $80.8 Million
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $6.41 Million - $15.4 Million
-1,077,871 Reduced 14.48%
6,364,694 $39.2 Million
Q2 2022

Aug 15, 2022

BUY
$10.6 - $13.28 $23.4 Million - $29.3 Million
2,204,384 Added 42.08%
7,442,565 $88.4 Million
Q1 2022

May 16, 2022

BUY
$10.37 - $12.73 $16.1 Million - $19.7 Million
1,547,888 Added 41.94%
5,238,181 $61.2 Million
Q4 2021

Feb 14, 2022

BUY
$10.21 - $15.27 $2.17 Million - $3.24 Million
212,144 Added 6.1%
3,690,293 $41.4 Million
Q3 2021

Nov 15, 2021

BUY
$14.07 - $17.3 $25.6 Million - $31.4 Million
1,816,020 Added 109.26%
3,478,149 $50.8 Million
Q2 2021

Aug 16, 2021

BUY
$16.62 - $18.94 $2.72 Million - $3.1 Million
163,507 Added 10.91%
1,662,129 $28.8 Million
Q1 2021

May 17, 2021

BUY
$15.15 - $19.78 $2.71 Million - $3.53 Million
178,667 Added 13.54%
1,498,622 $25.9 Million
Q4 2020

Feb 16, 2021

SELL
$16.86 - $19.67 $2.19 Million - $2.55 Million
-129,697 Reduced 8.95%
1,319,955 $24.3 Million
Q3 2020

Nov 16, 2020

SELL
$15.4 - $20.16 $3.15 Million - $4.12 Million
-204,549 Reduced 12.37%
1,449,652 $25.2 Million
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $17.4 Million - $20.4 Million
-951,730 Reduced 36.52%
1,654,201 $30.2 Million
Q1 2020

May 14, 2020

SELL
$16.28 - $25.63 $26.7 Million - $42.1 Million
-1,641,545 Reduced 38.65%
2,605,931 $52.5 Million
Q4 2019

Feb 14, 2020

BUY
$19.57 - $23.52 $43.9 Million - $52.7 Million
2,242,324 Added 111.83%
4,247,476 $98.9 Million
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $24.7 Million - $28.4 Million
1,245,818 Added 164.07%
2,005,152 $40.2 Million
Q2 2019

Aug 15, 2019

BUY
$17.59 - $21.1 $8.4 Million - $10.1 Million
477,465 Added 169.39%
759,334 $16 Million
Q2 2019

Aug 14, 2019

SELL
$17.59 - $21.1 $13.6 Million - $16.4 Million
-775,062 Reduced 73.33%
281,869 $17.8 Million
Q1 2019

May 14, 2019

SELL
$18.01 - $20.11 $10.1 Million - $11.3 Million
-561,305 Reduced 34.69%
1,056,931 $21.3 Million
Q4 2018

Feb 14, 2019

BUY
$17.44 - $21.53 $7.3 Million - $9.01 Million
418,675 Added 34.9%
1,618,236 $29.7 Million
Q3 2018

Nov 14, 2018

SELL
$19.97 - $21.96 $2.46 Million - $2.71 Million
-123,187 Reduced 9.31%
1,199,561 $25.6 Million
Q2 2018

Aug 14, 2018

SELL
$20.16 - $24.68 $3.33 Million - $4.08 Million
-165,307 Reduced 11.11%
1,322,748 $28.4 Million
Q1 2018

May 15, 2018

BUY
$20.31 - $24.95 $4.59 Million - $5.64 Million
226,173 Added 17.92%
1,488,055 $31.5 Million
Q4 2017

Feb 14, 2018

SELL
$20.99 - $23.89 $11 Million - $12.5 Million
-525,050 Reduced 29.38%
1,261,882 $28.9 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $35.9 Million - $39.1 Million
1,786,932
1,786,932 $39.1 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.14B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.